Sunmax Biotechnology Co - Stock

Sunmax Biotechnology Co Market capitalization 2024

Sunmax Biotechnology Co Market capitalization

17.67 B TWD

Ticker

4728.TWO

ISIN

TW0004728001

In 2024, Sunmax Biotechnology Co's market cap stood at 17.67 B TWD, a 49.78% increase from the 11.8 B TWD market cap in the previous year.

The Sunmax Biotechnology Co Market capitalization history

YEARREVENUE (undefined TWD)GROSS MARGIN (%)NET INCOME (undefined TWD)
20231.6983,18625.71
20221.485,20533.83
20211.0486,37245.64
20200.8681,93238.08
20190.5986,54100.45
20180.379,0374.66
20170.1972,3616.54
20160.1663,741.74
20150.1159,87-44.16
20140.1861,0020.24
20130.2165,2248.14
20120.1468,0316.26
20110.1577,7961.36
20100.1272,0425.17
20090.0563,65-9.37
20080.0352,07-31.58
20070.0321,03-41.9
20060.02-6,49-60.57

Sunmax Biotechnology Co Aktienanalyse

What does Sunmax Biotechnology Co do?

Sunmax Biotechnology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Sunmax Biotechnology Co's Market Capitalization

Sunmax Biotechnology Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Sunmax Biotechnology Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Sunmax Biotechnology Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Sunmax Biotechnology Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Sunmax Biotechnology Co Stock

What is the current Sunmax Biotechnology Co market capitalization?

The current market capitalization of Sunmax Biotechnology Co is 17.67 B TWD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Sunmax Biotechnology Co.

How has the market capitalization of Sunmax Biotechnology Co developed in recent years?

The market capitalization of Sunmax Biotechnology Co has increased/decreased by 49.78% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Sunmax Biotechnology Co?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Sunmax Biotechnology Co?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Sunmax Biotechnology Co have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Sunmax Biotechnology Co pay?

Over the past 12 months, Sunmax Biotechnology Co paid a dividend of 9.5 TWD . This corresponds to a dividend yield of about 2.93 %. For the coming 12 months, Sunmax Biotechnology Co is expected to pay a dividend of 9.5 TWD.

What is the dividend yield of Sunmax Biotechnology Co?

The current dividend yield of Sunmax Biotechnology Co is 2.93 %.

When does Sunmax Biotechnology Co pay dividends?

Sunmax Biotechnology Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sunmax Biotechnology Co?

Sunmax Biotechnology Co paid dividends every year for the past 2 years.

What is the dividend of Sunmax Biotechnology Co?

For the upcoming 12 months, dividends amounting to 9.5 TWD are expected. This corresponds to a dividend yield of 2.93 %.

In which sector is Sunmax Biotechnology Co located?

Sunmax Biotechnology Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sunmax Biotechnology Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sunmax Biotechnology Co from 8/8/2023 amounting to 9.5 TWD, you needed to have the stock in your portfolio before the ex-date on 7/18/2023.

When did Sunmax Biotechnology Co pay the last dividend?

The last dividend was paid out on 8/8/2023.

What was the dividend of Sunmax Biotechnology Co in the year 2023?

In the year 2023, Sunmax Biotechnology Co distributed 4.4 TWD as dividends.

In which currency does Sunmax Biotechnology Co pay out the dividend?

The dividends of Sunmax Biotechnology Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sunmax Biotechnology Co

Our stock analysis for Sunmax Biotechnology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sunmax Biotechnology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.